[Progress in AIDS therapy].
Mitsuya
Hiroaki
H
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000480:Alkynes; D019380:Anti-HIV Agents; D023241:Antiretroviral Therapy, Highly Active; D048588:Benzoxazines; D002986:Clinical Trials as Topic; D003521:Cyclopropanes; D015195:Drug Design; D024882:Drug Resistance, Viral; D019428:HIV Integrase Inhibitors; D006801:Humans; D007093:Imidazoles; D010078:Oxazines; D011480:Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D013454:Sulfoxides; D015215:Zidovudine
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D019428:HIV Integrase Inhibitors; D007093:Imidazoles; D010078:Oxazines; D011480:Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D013454:Sulfoxides; C506967:cenicriviroc; D015215:Zidovudine; C098320:efavirenz